RELMADA THERAPEUTICS, INC.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2021 | $-7.16 | $-9.07 |
| FY2022 | $-5.30 | $-9.22 |
| FY2023 | $-3.28 | $-3.48 |
| FY2024 | $-2.65 | $-3.39 |
| FY2025 | $-1.45 | $-3.26 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2021 | $-7.16 | $-9.07 |
| FY2022 | $-5.30 | $-9.22 |
| FY2023 | $-3.28 | $-3.48 |
| FY2024 | $-2.65 | $-3.39 |
| FY2025 | $-1.45 | $-3.26 |